ArrowMark Colorado Holdings LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 128 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2013. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
ArrowMark Colorado Holdings LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2013$2,109,000
+168.7%
59,523
+18.3%
0.07%
-66.8%
Q2 2013$785,000–50,295–0.21%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2013
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders